477.73
Schlusskurs vom Vortag:
$308.88
Offen:
$445.59
24-Stunden-Volumen:
4.47M
Relative Volume:
8.79
Marktkapitalisierung:
$13.73B
Einnahmen:
$2.16B
Nettoeinkommen (Verlust:
$416.39M
KGV:
36.47
EPS:
13.1
Netto-Cashflow:
$540.93M
1W Leistung:
+52.77%
1M Leistung:
+54.43%
6M Leistung:
+38.40%
1J Leistung:
+9.28%
Medpace Holdings Inc Stock (MEDP) Company Profile
Firmenname
Medpace Holdings Inc
Sektor
Branche
Telefon
(513) 579-9911
Adresse
5375 MEDPACE WAY, CINCINNATI, OH
Vergleichen Sie MEDP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MEDP
Medpace Holdings Inc
|
477.73 | 8.99B | 2.16B | 416.39M | 540.93M | 13.10 |
![]()
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-24 | Eingeleitet | Barclays | Equal Weight |
2025-04-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
2025-03-24 | Eingeleitet | Leerink Partners | Market Perform |
2024-10-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
2024-09-27 | Herabstufung | UBS | Buy → Neutral |
2024-09-25 | Herabstufung | Jefferies | Buy → Hold |
2024-08-01 | Eingeleitet | Truist | Hold |
2024-05-29 | Eingeleitet | TD Cowen | Buy |
2024-05-28 | Eingeleitet | Mizuho | Buy |
2024-04-23 | Hochstufung | Jefferies | Hold → Buy |
2024-03-18 | Eingeleitet | Deutsche Bank | Hold |
2024-02-15 | Hochstufung | UBS | Neutral → Buy |
2023-10-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-05-08 | Hochstufung | Guggenheim | Neutral → Buy |
2022-10-27 | Hochstufung | UBS | Sell → Neutral |
2022-09-07 | Eingeleitet | UBS | Sell |
2022-05-24 | Eingeleitet | Guggenheim | Neutral |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2020-10-02 | Hochstufung | Truist | Hold → Buy |
2020-06-08 | Hochstufung | Robert W. Baird | Underperform → Neutral |
2020-05-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2020-04-30 | Hochstufung | SunTrust | Sell → Hold |
2020-04-20 | Herabstufung | Robert W. Baird | Neutral → Underperform |
2020-03-17 | Herabstufung | SunTrust | Hold → Sell |
2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
2018-10-31 | Hochstufung | SunTrust | Hold → Buy |
2018-09-17 | Eingeleitet | SunTrust | Hold |
2018-07-31 | Hochstufung | William Blair | Mkt Perform → Outperform |
2017-11-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
2017-09-29 | Eingeleitet | Raymond James | Mkt Perform |
2017-07-10 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Medpace Holdings Inc Aktie (MEDP) Neueste Nachrichten
Medpace's Earnings Surge: A Deep Dive into Q2 Outperformance and 2025 Guidance - AInvest
Medpace Holdings Reports Strong Q2 2025 Growth - TipRanks
Medpace Holdings 2025 Q2 Earnings Beats Expectations with Net Income Up 2.2% - AInvest
Medpace Beats Q2 Revenue Estimates - The Motley Fool
Medpace Holdings stock just popped by 50%, but why? - Mugglehead Magazine
Medpace Holdings Inc. Q2 Earnings Call Highlights - TipRanks
Medpace Holdings Surges to 31st in Trading Volume with 21.13 Billion Shares Exchanged - AInvest
The stock price surged nearly 55%! Medpace's Q2 performance exceeded expectations, boosting the Concept of CRO stocks. - 富途牛牛
What analysts say about Medpace Holdings Inc. stockPhenomenal wealth increase - jammulinksnews.com
Market Today: Medpace (MEDP) Surges 45% on Earnings Beat - GuruFocus
What drives Medpace Holdings Inc. stock priceConsistently superior profits - jammulinksnews.com
Medpace Holdings (MEDP) Boosts 2025 Revenue Outlook - GuruFocus
Medpace Holdings Exceeds Expectations with 14.2% YoY Revenue Growth - AInvest
Medpace's performance exceeded expectations, achieving the largest single-day increase in nearly nine years during trading, driving up stocks in the CRO Concept. - 富途牛牛
Medpace stock soars 53% in trading Tuesday; here’s why - The Business Journals
Medpace Stock Rockets: What’s Fueling It? - timothysykes.com
Medpace's Resilient Growth: A CRO's Strategic Edge in a Shifting Landscape - AInvest
Kohl’s, Medpace, General Motors, Lockheed Martin, Northrop Grumman: Stocks Making The Biggest Moves Today - Investing.com India
The CRO Sector's Quiet Revolution: How Medpace and IQVIA Are Leading the Charge - AInvest
Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase (MEDP) - Seeking Alpha
Medpace Holdings Stock Soars 49.3% After Robust Q2 ResultsNews and Statistics - IndexBox
Medpace Holdings Inc. Stock Analysis and ForecastUnprecedented profits - Autocar Professional
Medspace Stock Is Trading Higher Tuesday: What's Going On? - Benzinga
Why Is Medpace (MEDP) Stock Rocketing Higher Today - Yahoo Finance
GM, Lockheed, Northrop Grumman, D.R. Horton, Philip Morris, Medpace, and More Market Movers - Barron's
Earnings call transcript: Medpace’s Q2 2025 earnings surpass expectations - Investing.com
Medpace Stock Soars on Surpassing Expectations - timothysykes.com
Medpace stock price target maintained at $300 by UBS on mixed outlook - Investing.com Nigeria
Earnings call transcript: Medpace’s Q2 2025 earnings surpass expectations By Investing.com - Investing.com UK
Medpace Stock Just Soared 50%. What Caused It to Pop. - Barron's
Medpace rockets on earnings beat, guidance raise - Sherwood News
Medpace Holdings: A Surprising Climb - StocksToTrade
Medpace Holdings stock hits 52-week high at 445.59 USD - Investing.com Australia
Medpace Rides Out Swings With Strong Profits And Growth Plans - Finimize
Iqvia stock, Medpace stock up after Q2 beats (IQV:NYSE) - Seeking Alpha
First Look: Medpace Surges, Sanofi Expands, Oracle Eyes Cloud De - GuruFocus
D.R. Horton, Medpace, IQVIA - TradingView
Is Medpace Holdings Inc. a good long term investmentFree Smart Trading Workshop - jammulinksnews.com
Medpace Holdings’ revenue increases 14.2% in Q2 2025 - Medical Buyer
S&P 500 Futures Decline in Premarket Trading; Medpace Holdings, IQVIA Holdings Lead - Barron's
These Stocks Are Moving the Most Today: GM, Opendoor, Medpace, NXP Semiconductors, D.R. Horton, Lockheed Martin, and More -- Barrons.com - 富途牛牛
Medpace Raises FY2025 Outlook Again, Stock Surges Over 40% in Pre-Market Trading - AInvest
Medpace Raises FY2025 Outlook Yet Again, Stock Soars - Nasdaq
Why Medpace Shares Are Trading Higher By 45%; Here Are 20 Stocks Moving Premarket - 富途牛牛
These Stocks Are Moving the Most Today: Opendoor, Medpace, NXP Semiconductors, Agilysys, GM, Lockheed Martin, and More -- Barrons.com - 富途牛牛
Medpace Holdings (MEDP) Surges on Strong Earnings and Guidance H - GuruFocus
Medpace Holdings Soars 44.39% on Strong Q2 Earnings - AInvest
Medpace: Q2 Earnings Snapshot - Norwalk Hour
Medpace Retail Trader Optimism Abounds As Stock Poised For Best Day Ever On Q2 Beat, Outlook - MSN
Medpace Retail Trader Optimism Abounds As Stock Poised For Best Day Ever On Q2 Beat, Outlook By Stocktwits - Investing.com India
Medpace Holdings 2025 Q2 Earnings Beats Expectations with Net Income Growth - AInvest
Finanzdaten der Medpace Holdings Inc-Aktie (MEDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):